| Ytd | 43.87% | |
| 1y | 150.56% |
| Open | 2.19 | Prev Close | 2.19 | Low | 2.05 | High | 2.25 | Mkt Cap | 141.00M |
| Vol | 0.00 | Avg Vol | 854.35K | EPS | -0.32 | P/E | -6.97 | Forward P/E | -0.47 |
| Beta | 1.83 | Short Ratio | 0.53 | Inst. Own | 20.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 2.72 | 200-d Avg | 1.89 | 1yr Est | 3.33 |
EQ News
Shares of Equillium, Inc. (NASDAQ: EQ - Get Free Report) have received a consensus rating of "Modera
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Equillium (NASDAQ:EQ) with a Overweigh
Three-year renewal follows early campaign results that delivered up to 40% increases in average orde
LA JOLLA, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology in
Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammator
Equillium NASDAQ: EQ Chief Scientific Officer Stephen Connelly outlined new preclinical data during
LA JOLLA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology inn
LA JOLLA, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology inn
Phase 1 proof-of-mechanism study of EQ504 on track to initiate in mid-2026, with data expected appro
LA JOLLA, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology inn
DealTrax Highlights Include: Powerful Tools & Streamlined Processes: Quick, efficient deal setup wit
LA JOLLA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology i
Aberdeen Group plc grew its holdings in Equillium, Inc. (NASDAQ: EQ) by 523.6% in the undefined quar
LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology i
LA JOLLA, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology i
Initiation of Phase 1 proof-of-mechanism study of EQ504 planned for mid-2026, with data expected app
LA JOLLA, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology i
Equillium, Inc. (NASDAQ: EQ - Get Free Report) COO Christine Zedelmayer sold 120,312 shares of the s
Capital strengthens the advancement of EQ504 through key clinical milestones Anticipated net proceed
Equillium (EQ) remains a 'Hold' as it advances EQ504 for ulcerative colitis, with phase 1 trial init
LA JOLLA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology in
On Friday, 497 companies set new 52-week lows.
During Friday's trading, 293 companies set new 52-week lows.
Monday saw 196 companies set new 52-week lows.
On Monday, 413 companies reached new 52-week lows.
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after ju
On Thursday, 216 stocks hit new 52-week lows.
On Wednesday, 329 companies hit new 52-week lows.
On Monday, 198 companies reached new 52-week lows.
On Friday, 153 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Gainers Universal Security Instruments, Inc. (NYSE: UUU) shares climbed 62.3% to close at $5.00 o
70 Biggest Movers From Yesterday
41 Biggest Movers From Yesterday